Blockade of human atrial 5-HT4 receptors by GR 113808. |
| |
| Authors: | A. J. Kaumann |
| |
| Affiliation: | Clinical Pharmacology Unit, Cambridge University, Addenbrooke''s Hospital. |
| |
| Abstract: | 1. The mode of antagonism of 5-hydroxytryptamine (5-HT)-induced positive inotropic effects by the highly selective 5-HT4 receptor antagonist GR 113808 ([1-[2-methylsulphonylamino ethyl]-4-piperidinyl]methyl 1-methyl-1H-indole-3-carboxylate) was investigated on isolated preparations of human right atrium. 2. GR 113808 caused concentration-dependent (2-100 nM) surmountable antagonism of the effects of 5-HT with a pKB (M) of 8.8. 3. The affinity of GR 113808 for human atrial 5-HT4 receptors, together with its high selectivity for 5-HT4 receptors comprise useful properties for investigating the question of 5-HT4 receptor subtypes. |
| |
| Keywords: | |
|
|
